Addition of incretin therapy to metformin in type 2 diabetes

Findings from today's study show the superiority of 1.8 mg versus 1.2 mg liraglutide for reduction of HbA^sub 1c^, but this result has not been recorded in previous studies (table).7 Only the 1.8 mg dose of liraglutide was assessed in LEAD-6,2 in which liraglutide once daily was shown to be sup...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 375; no. 9724; pp. 1410 - 1412
Main Authors:	Scheen, André J, Radermecker, Régis P
Format:	Journal Article Web Resource
Language:	English
Published:	England Elsevier Ltd 24-04-2010 Elsevier Limited Lancet Publishing Group
Subjects:	Diabetes Diabetes Mellitus, Type 2 - drug therapy Drug Therapy, Combination Endocrinologie, métabolisme & nutrition Endocrinology, metabolism & nutrition Glucagon-Like Peptide 1 Human health sciences Humans Hypoglycemic Agents - therapeutic use incretin Incretins - therapeutic use Internal Medicine metformin Metformin - therapeutic use Pharmacie, pharmacologie & toxicologie Pharmacy, pharmacology & toxicology Sciences de la santé humaine type 2 diabetes
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!